Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL02
- Pharmacological subgroupL02A
- Chemical subgroupL02AE
- Chemical substanceL02AE01Buserelin
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 7 registrations
- Suprefact1 MG / ML · Solution · Cheplapharm Arzneimittel GMBH
- Suprefact Depot 2 Months6.3 MG · Implant · Cheplapharm Arzneimittel GMBH
- Suprefact Depot 3 Months9.45 MG · Implant · Cheplapharm Arzneimittel GMBH
- Suprefact100 MCG / ACT · Solution · Cheplapharm Arzneimittel GMBH
Spain
AEMPS · 4 registrations
At a glance
- ATC code
- L02AE01
- Registers
- 5
- Registrations
- 15
- With their own page
- 8
- Companies
- 5
All medicines with Buserelin
Human medicines from every register that match Buserelin by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
15 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| SUPREFACT 1 mg/ml SOLUCION INYECTABLE | Spain | 1,050 mg | solución inyectable | Marketed | Cheplapharm Arzneimittel Gmbh |
| SUPREFACT DEPOT 9,45 mg IMPLANTE | Spain | 9,9 mg | implante | Marketed | Cheplapharm Arzneimittel Gmbh |
| Suprefact Depot 3 maanden, implantatiestift 9,45 mg | Netherlands | Implantaat | Authorised | CHEPLAPHARM Arzneimittel GmbH | |
| Suprefact Depot 3 maanden, implantatiestift 9,45 mg | Netherlands | Implantaat | Authorised | Medcor Pharmaceuticals B.V. | |
| Suprefact | Canada | 1 MG / ML | Solution | Marketed | Cheplapharm Arzneimittel GMBH |
| Any | New Zealand | Inj 1 mg per ml, 5.5 ml vial | Funded | ||
| Suprefact Depot 2 Months | Canada | 6.3 MG | Implant | Not marketed | Cheplapharm Arzneimittel GMBH |
| Suprefact Depot 3 Months | Canada | 9.45 MG | Implant | Not marketed | Cheplapharm Arzneimittel GMBH |
| SUPREFACT 100 microgramos/PULSACION SOLUCION PARA PULVERIZACION NASAL | Spain | 1,050 mg | solucion para pulverizacion nasal | Suspended | Cheplapharm Arzneimittel Gmbh |
| SUPREFACT DEPOT 6,3 mg IMPLANTE EN JERINGA PRECARGADA | Spain | 6,6 mg | implante | Suspended | Cheplapharm Arzneimittel Gmbh |
| Suprefact | Canada | 100 MCG / ACT | Solution | Cancelled | Cheplapharm Arzneimittel GMBH |
| Suprefact Depot | Brazil | Cancelled | Sanofi-Aventis Farmacêutica Ltda | ||
| Suprefact Inj 1MG/ML | Canada | 1 MG / ML | Liquid | Cancelled | Hoechst Canada INC. |
| Suprefact Intranasal Solution 1MG/ML | Canada | 1 MG / ML | Spray | Cancelled | Hoechst Canada INC. |
| Suprefact Liq 1MG/ML | Canada | 1 MG / ML | Liquid | Cancelled | Hoechst Roussel Canada INC. |